CN Patent

CN104478959A — 含腈基联苯双葡萄糖苷结构化合物、其制备方法和用途

Assigned to Foshan Saiweisi Pharmaceutical Technology Co Ltd · Expires 2015-04-01 · 11y expired

What this patent protects

本发明涉及与糖尿病相关的药物领域。具体而言，本发明涉及一类含腈基联苯双葡萄糖苷结构的2型钠依赖性葡萄糖转运子(SGLT2)抑制剂、其制备方法、以及在制备糖尿病药物中的应用。

USPTO Abstract

本发明涉及与糖尿病相关的药物领域。具体而言，本发明涉及一类含腈基联苯双葡萄糖苷结构的2型钠依赖性葡萄糖转运子(SGLT2)抑制剂、其制备方法、以及在制备糖尿病药物中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN104478959A
Jurisdiction
CN
Classification
—
Expires
2015-04-01
Drug substance claim
No
Drug product claim
No
Assignee
Foshan Saiweisi Pharmaceutical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.